筛选条件 共查询到500条结果
排序方式
Soluble guanylate cyclase stimulators in patients with heart failure with reduced ejection fraction across the risk spectrum

期刊: EUROPEAN JOURNAL OF HEART FAILURE, 2022; 24 (11)

Patients with heart failure with reduced ejection fraction (HFrEF) have a high residual risk of adverse outcomes, even when treated with optimal guide......

JIF:6.008

Impact of anaemia and the effect of empagliflozin in heart failure with reduced ejection fraction: findings from EMPEROR-Reduced

期刊: EUROPEAN JOURNAL OF HEART FAILURE, 2022; 24 (4)

Aims Anaemia is frequent among patients with heart failure (HF) and reduced ejection fraction (HFrEF) and is associated with poor outcomes. Sodium-glu......

JIF:6.008

Quantified mitral regurgitation and left atrial function in heart failure with reduced ejection fraction: interplay and outcome implications

期刊: EUROPEAN JOURNAL OF HEART FAILURE, 2022; 24 (4)

Aims The clinical and prognostic importance of functional mitral regurgitation (FMR) in heart failure patients with reduced ejection fraction (HFrEF) ......

JIF:6.008

Is it time to shift our focus from treatment to prevention of heart failure with a mineralocorticoid receptor antagonist? COMMENT

期刊: EUROPEAN JOURNAL OF HEART FAILURE, 2022; 24 (4)

This article refers to 'Screening-guided spironolactone treatment of subclinical left ventricular dysfunction for heart failure prevention in at-risk ......

JIF:6.008

Use of evidence-based therapy in heart failure with reduced ejection fraction across age strata

期刊: EUROPEAN JOURNAL OF HEART FAILURE, 2022; 24 (6)

Aims In older patients, guideline-directed medical therapy (GDMT) for heart failure (HF) with reduced ejection fraction (<40%; HFrEF) is not contra......

JIF:6.008

共500条页码: 1/34页15条/页